PATERNA, Salvatore
 Distribuzione geografica
Continente #
NA - Nord America 6.251
EU - Europa 2.754
AS - Asia 886
AF - Africa 22
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 9.924
Nazione #
US - Stati Uniti d'America 6.240
IT - Italia 702
UA - Ucraina 631
FI - Finlandia 504
CN - Cina 471
SG - Singapore 288
IE - Irlanda 209
DE - Germania 179
GB - Regno Unito 152
FR - Francia 103
SE - Svezia 74
RU - Federazione Russa 70
PL - Polonia 56
KR - Corea 34
JP - Giappone 31
IN - India 27
CI - Costa d'Avorio 20
BE - Belgio 15
RO - Romania 15
NL - Olanda 14
CA - Canada 11
CH - Svizzera 10
IR - Iran 10
TR - Turchia 8
ES - Italia 6
BR - Brasile 5
UZ - Uzbekistan 5
HK - Hong Kong 4
AT - Austria 3
EU - Europa 3
LB - Libano 3
CZ - Repubblica Ceca 2
GR - Grecia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
ET - Etiopia 1
HU - Ungheria 1
ID - Indonesia 1
IQ - Iraq 1
KH - Cambogia 1
LT - Lituania 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 9.924
Città #
Fairfield 856
Houston 534
Ashburn 501
Woodbridge 493
Chandler 451
Wilmington 416
Jacksonville 351
Ann Arbor 328
Seattle 312
Cambridge 284
Singapore 230
Dublin 209
Palermo 174
Medford 156
Des Moines 134
Nanjing 131
Princeton 102
Tulsa 92
Altamura 87
Boardman 76
San Diego 68
Santa Clara 61
Lawrence 59
Kraków 55
Dearborn 47
Nanchang 43
Shenyang 42
Beijing 41
New York 35
Hebei 33
Seongnam 32
Venice 29
Milan 28
Jinan 23
Changsha 22
Jiaxing 21
Abidjan 20
San Mateo 20
Verona 20
Kumar 18
London 16
Ludwigshafen am Rhein 16
Ningbo 16
Kunming 15
Tianjin 15
Brussels 14
Munich 13
Los Angeles 11
Zhengzhou 11
Auburn Hills 10
Falls Church 10
Düsseldorf 9
Norwalk 9
San Paolo di Civitate 9
Taizhou 9
Izmir 8
Ottawa 8
Phoenix 8
Saint Petersburg 8
Tehran 8
Helsinki 7
Chicago 6
Columbus 6
Dallas 6
Guangzhou 6
Kilburn 6
Moscow 6
Napoli 6
Redwood City 6
Siena 6
Springfield 6
Haikou 5
Kiev 5
Amsterdam 4
Durham 4
Hefei 4
Irún 4
Lanzhou 4
Mcallen 4
Prineville 4
Rome 4
Taiyuan 4
Bologna 3
Civitanova Marche 3
Den Haag 3
Detroit 3
Forest City 3
Hangzhou 3
Hounslow 3
New Bedfont 3
Orange 3
Vienna 3
Worcester Park 3
Yokohama 3
Zurich 3
Bagheria 2
Bari 2
Berlin 2
Bresso 2
Catanzaro 2
Totale 7.019
Nome #
Hypertonic Saline in Conjunction with High-Dose Furosemide Improves Dose–Response Curves in Worsening Refractory Congestive Heart Failure 256
Fever of unclear origin and cytopenia because of acute splenic sequestration in a young immunocompetent carrier of Beta-globin mutation for hb valletta. 249
The pathophysiology of acute heart failure: the key role of fluid accumulation 184
Effects of canrenoate plus angiotensin-converting enzyme inhibitors versus angiotensin-converting enzyme inhibitors alone on systolic and diastolic function in patients with acute anterior myocardial infarction 178
Early carotid atherosclerosis and cardiac diastolic abnormalities in hypertensive subjects 170
Combination of indomethacin and statin compared with indomethacin and placebo in patients with a first episode of acute pericarditis: preliminary findings. 163
Changes in Brain Natriuretic Peptide Levels and Bioelectrical Impedance Measurements After Treatment With High-Dose Furosemide and Hypertonic Saline Solution Versus High-Dose Furosemide Alone in Refractory Congestive Heart Failure A Double-Blind Study 162
Blood urea nitrogen to creatinine ratio is associated with congestion and mortality in heart failure patients with renal dysfunction 161
Medium-Term Effects of Bisoprolol Administration on Renal Hemodynamics and Function in Mild to Moderate Essential Hypertension 158
The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure. 157
Combination of a high bolus dose of tirofiban with half-dose thrombolytics for the treatment of subacute stent thrombosis 149
Clinical trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites. 149
Troponin I release after intravenous treatment with high furosemide doses plus hypertonic saline solution in decompensated heart failure trial (Tra-HSS-Fur) 148
Is delayed facilitated percutaneous coronary intervention better than immediate in reperfused myocardial infarction? Six months follow up findings 140
Changes in estimating echocardiography pulmonary capillary wedge pressure after hypersaline plus furosemide versus furosemide alone in decompensated heart failure. 137
Role of segmental and whole body bioelectrical impedance analysis in acute heart failure diagnosis. 134
Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide 134
A new option in measuring bioimpedance in congestive heart failure 131
Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction 131
Lymphocyte beta-adrenergic receptors in young subjects with peripheral or central obesity: relationship with central haemodynamics and left ventricular function 130
Wet BNP, fluid and hemodynamic status at discharge in Acute Heart Failure. 129
Does angiotensin-converting enzyme gene polymorphism affect blood pressure? Findings after 6 years of follow-up in healthy subjects 126
Safety and feasibility of atropine added in patients with sub-maximal heart rate during exercise myocardial perfusion SPECT. 126
Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? 126
Impact of "Off-Label" Use of Ivabradine on Exercise Capacity, Gas Exchange, Functional Class, Quality of Life, and Neurohormonal Modulation in Patients With Ischemic Chronic Heart Failure 124
Relationship between ACE-DD polymorphism and diastolic performance in healthy subjects 122
Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. 122
Short-term walking physical training and changes in body hydration status, B-type natriuretic peptide and C-reactive protein levels in compensated congestive heart failure. 122
Comparison of ivabradine versus metoprolol in early phases of reperfused anterior myocardial infarction with impaired left ventricular function: preliminary findings. 120
Water and Sodium in Heart Failure: A Spotlight on Congestion. 120
Are BNP plasma levels useful in heart failure diagnosis each time? A dyspneic patient with anasarca 119
Long-Term Effects of Dietary Sodium Intake on Cytokines and Neurohormonal Activation in Patients With Recently Compensated Congestive Heart Failure 118
Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study). 118
Is there any novelty on the horizon of heart failure management in internal medicine? The evaluation of body fluid accumulation 114
Immediate versus delayed facilitated percutaneous coronary intervention. A pilot study 112
CARDIOPULMONARY EXERCISE TESTING IN PATIENTS WITH CHRONIC HEART FAILURE: PROGNOSTIC COMPARISON FROM PEAK VO2 AND VE/VCO2 SLOPE. 112
Two-dimensional echocardiographic evaluation of left ventricular ejection fraction by the ellipsoid single-plane algorithm: a reliable method for assessing low or very low ejection fraction values? 110
Evaluation of regional haemodynamics and alterations of vascu¬lar wall of the lower limbs in hypertensive subjects 108
Novel strategies: challenge loop diuretics and sodium management in heart failure--part II. 106
High dose torasemide is equivalent to high-dose furosemide with Hypertnic saline in the treatment of refractory congestive heart failure 105
Left ventricular function response to exercise in normotensive obese subjects: influence of degree and duration of obesity. 104
ASSOCIAZIONE TRA HS-PCR E DIMENSIONI DELL'ATRIO SINISTRO IN IPERTESI MAI TRATTATI IN RITMO SINUSALE 103
Time to ferry heart failure onto new shores: the need to effectively customize long-term therapy. 101
cardiovascular effects of I/D angiotensin converting enzyme gene polymorphismin healty subjects: Findings after follow-up of six years 100
Association between reduced lymphocyte beta-adrenergic receptors and left ventricular dysfunction in young obese subjects 100
Effect of physiscal training on exercise capacity, gas exchange and N-terminal pro-brain natriuretic peptide levels in patients with chronic heart failure 99
Early and personalized ambulatory follow-up to tailor furosemide and fluid intake according to congestion in post-discharge heart failure 99
An unusual presentation of massive pulmonary embolism mimicking septal acute myocardial inferction treated with tenecteplase 93
Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction. 92
Bed-side inferior vena cava diameter and mean arterial pressure predict long-term mortality in hospitalized patients with heart failure: 36 months of follow-up 92
Tolerability and efficacy of high-dose furosemide and small-volume hypertonic saline solution in refractory congestive heart failure 91
EFFECT OF CANREONATE PLUS ANGIOTENSIN-CONVERTING ENZYME INHIBITORS VERSUS ANGIOTENSIN-CONVERTNG ENZYME INHIBITORS AOLNE ON SYSTOLIC AND DIASTOLIC FUNCTION IN PATIENTS WITH ACUTE ANTERIOR MYOCARDIAL INFARCTION 90
Is there a link between liver steatosis, carotid atherosclerosis and C-reactive protein in metabolic and non-metabolic patients? 90
Long-term effects on immune-inflammatory and neuro-endocrine pathways of a new therapeutic strategy for advanced heart failure 89
Changes in natriuretic peptides and cytokines plasma levels in patients with heart failure, after high dose of furosemide plus small volume saline solution (HSS) and after an acute saline loading 88
One-year renal and cardiac effects of bisoprolol versus losartan in recently diagnosed hypertensive patients: a randomized, double-blind study. 88
Use of bivalirudin for heparin-induced thrombocytopaenia after thrombolysis in massive pulmonary embolism: a case report. 86
The challenge of the volume status assessment in heart failure. 84
A case of febrile illness and multiple pulmonary embolism in a young woman acting hormonal contrapceptives. 83
Long-term effect on immune-inflammatory and neuro-endocrine pathways of a new therapeutic strategy for advanced heart failure 83
Severe Brochostenosis by Oral Propafenone Immediately After Commencing Treatment. 83
Bioelectrical Impedance Analysis and prediction of hospitalization for heart failure in ambulatory patients with symptomatic left ventricular dysfunction: preliminary data 82
Intravenous high dose furosemide plus small volume of hypertonic saline solution (HSS) versus seriated paracentesis in treatment of refractory ascites. 81
Six-month echocardiographic study in patients with submassive pulmonary embolism and right ventricle dysfunction: comparison of thrombolysis with heparin. 81
Biolectrical impedance analysis as a new diagnostic tool for heart failure diagnosis in parimary care: preliminary data 80
evaluation of BNP plasma levels and bioelectrical impedance analysis (BIA) in decompensated heart failure. A double blind study 79
Thrombolysis for massive pulmonary embolism in pregnancy: a case report. 78
Early ultrasonographic markers of atherosclerosis in adul white recent onset of primary hypertension and familial history of cardiovascular event 75
impedance analyisis to predict rehospitalization due to worsening of congestive heart failure in anbulatory patients 73
Clinical-anamnestic and instrumental data in outpatients suffering from venous disease 73
Non alcoholic liver steatosis asymptomatic carotid atherosclerosis and C-reactive protein in diabetic and non-diabetic patients. 72
Ultrasonography NAFLD subclinical carotid atherosclerosis and inflammatory markers in patients with and without metabolic syndome. 72
Role of segmental and whole body bioelecttrical impedance analisys (BIA) in acute heart failure diagnosis 71
Small-volume hypertonic saline solution and high-dosage furosemide in the treatment of refractory congestive heart failure. A pilot study 71
Unusual case of recurrent pyrexia of unknown origin and cytopenia due to acute splenic sequestration crisis in a young patient with splenomegaly and beta-globin mutation for Hb-Valletta 69
Bioelectrical impedance parameters versus BNP testing to differentiate decompensated heart failure from chronic obstructive pulmonary disease. 68
Intravenous high dose furosemide plus small volume of hypertonic saline solution (HSS) versus seriated paracentesis in treatment of refractory ascites: a pilot study 68
Whole-body and segmental bioelectrical impedance analyisis to predict rehospitalization due to worsening of congestive heart failure in anbulatory patients 68
Relationship between non-invasive measurement of endothelial function and familial hystory of cardiovascular event in hypertensives subjects of recent onset. 67
Sodium: an ld emery or a new friend for advanced failured patients? 66
Intavenous high dose furosemide plus small volume of hypertonic saline solutions (HSS) versus seriated paracentesis in treatment of refractory ascites: a pilot study 66
heart failure, after high dose of furosemide plus small volume saline solution (HSS) and after an acute saline loading 66
delayed facilitated percutaneous coronary intervention versus immediate in reperfused stemi 65
One year atorvastatin treatment in patients with familial hypercholesterolemia: effect on CRP and fibrinogen 62
Relationship between ultrasonographic measurements of inferior vena cava and bioelectrical impedance analysis parameters in patients with decompensated congestive heart failure. 59
Echocardiographic PCWP evaluation in decompensated heart failure: relationship with B-type natriuretic peptide and bioelectrical impedance anaysis. 59
Evaluation of BNP levels and bioelectrical impedance measurements after a novel therapy of refractory congestive heart failure 58
Steatosi epatica non-alcolica e aterosclerosi carotidea asintomatica in soggetti con e senza sindrome metabolica: uno studio caso-controllo 58
Obesity and iron deficiency anemia as risk factors for asymptomatic bacteriur 57
acute coronary syndrome following large-volume paracentesis. Case report and pathophysiology 56
Safety of bioelectrical impedance analysis inevaluation of patient with liver chirrosis and relation with severity of disease. 56
OMEGA 3 FATTY ACIDS LEVEL: REDUCTION RISK OF SUDDEN DEATH FROM MYOCARDIAL INFARCTION 55
Cardiovascular Effects of I/D angiotension converting enzyme gene polymorphism in heathy subjects 55
Sensitivity, Specifity and Predictive value of the Echocardiography and Troponin- T test combination in patients with non-St Elevetion Acute Coronary Syndromes 55
The dry weight maintainance, estimated with bioelectrical impedance analysis, predicts freedom from congestion and post-discharge clinical outcome in ambulatory heart failure despite previous class III-IV symptoms 55
One year atorvastatin treatment in patients with familial hypercholesterolemia: effects on CRP and fibrinogen 54
Safwty of bioelectrical impedance analysis inevaluation of patient with liver chirrosis and relation with severity of disease 54
One year atorvastatin treatment in patients with familial hypercholesterolrmia: effects on CRP and fibrinogen 53
Delayed facilitated percutaneous coronary intervention is better than immediate in reperfused myocardial infarction 52
Ultrasonography of the inferior vena cava and analysis of bioelectrical impedance in the assessment of decompensated heart failure. 49
Totale 10.056
Categoria #
all - tutte 35.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.045


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.633 0 0 0 0 278 320 289 144 275 83 134 110
2020/20211.324 58 141 89 139 118 54 145 78 154 85 133 130
2021/20221.068 36 296 34 32 33 18 79 45 121 112 62 200
2022/20231.322 137 242 9 121 164 227 110 94 142 5 53 18
2023/2024506 27 81 29 50 45 114 36 29 6 14 3 72
2024/2025507 39 207 115 134 12 0 0 0 0 0 0 0
Totale 10.147